Actualités

Chiesi Group announces the passing of Honorary President Dr. Paolo Chiesi (1940-2024)

Parma, March 5th, 2024 - Chiesi Group announces the passing of Honorary President Dr. Paolo Chiesi, a fundamental pillar of the company who shaped its history alongside his brother Alberto.Born in...

1/21

Chiesi Global Rare Diseases Announces Publication of Results from Phase 3 BALANCE Study in Fabry Disease

2/21

Chiesi’s 2022 Sustainability Report: “Purpose First”

3/21

ARCHIVES

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc

17 May 2023 Actualités

2022 for Chiesi: The Group’s international growth continues

17 April 2023 Actualités

Chiesi Group and Affibody collaborate to develop and commercialize innovative treatments for respiratory diseases

14 March 2023 Actualités

Chiesi appoints Giuseppe Accogli as new Group CEO

01 February 2023 Actualités

Chiesi accelerates path toward full sustainability despite Covid-19 pandemic

23 June 2021 Actualités

Journée Mondiale de l’asthme: Communiqué de presse

05 May 2021 Actualités

CHIESI POURSUIT SA TRANSFORMATION CULTURELLE AVEC UNE NOUVELLE IDENTITÉ VISUELLE, VÉRITABLE REFLET DU LANGAGE ET DE L’EXPÉRIENCE DE SES PATIENTS.

22 March 2021 Actualités

Chiesi Group: performance is up in 2020

09 March 2021 Actualités

European market authorisation for the extrafine triple combination therapy

05 February 2021 Actualités

COLLABORATION ENTRE KAIA HEALTH ET LE GROUPE CHIESI

30 November 2020 Actualités

Journée de la BPCO

17 November 2020 Actualités

Collaboration entre Moderna et le groupe Chiesi

17 September 2020 Actualités

10 Ans Chiesi Belgique

02 September 2020 Actualités

Chiesi publishes its annual report

23 July 2020 Actualités

Climbing For Life

09 June 2020 Actualités

Dimanche 31 mai - Journée mondiale sans tabac

30 May 2020 Actualités

SSMG

07 April 2020 Actualités

Chiesi Belgique & COVID-19 Pandemic

03 April 2020 Actualités